AM
Atwater Malick’s Pfizer PFE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-149,761
| Closed | -$4.16M | – | 81 |
|
|
2024
Q1 | $4.16M | Sell |
149,761
-24,178
| -14% | -$671K | 1.46% | 25 |
|
|
2023
Q4 | $5.01M | Buy |
173,939
+8,100
| +5% | +$233K | 1.96% | 23 |
|
|
2023
Q3 | $5.5M | Buy |
165,839
+1,964
| +1% | +$65.1K | 2.42% | 19 |
|
|
2023
Q2 | $6.01M | Buy |
163,875
+7,683
| +5% | +$282K | 2.57% | 18 |
|
|
2023
Q1 | $6.37M | Buy |
156,192
+4,407
| +3% | +$180K | 2.99% | 18 |
|
|
2022
Q4 | $7.78M | Buy |
151,785
+4,264
| +3% | +$218K | 3.83% | 13 |
|
|
2022
Q3 | $6.46M | Buy |
147,521
+2,979
| +2% | +$130K | 3.61% | 16 |
|
|
2022
Q2 | $7.58M | Buy |
144,542
+2,374
| +2% | +$124K | 3.99% | 8 |
|
|
2022
Q1 | $7.36M | Buy |
142,168
+4,734
| +3% | +$245K | 3.55% | 13 |
|
|
2021
Q4 | $8.12M | Buy |
137,434
+3,142
| +2% | +$186K | 3.77% | 9 |
|
|
2021
Q3 | $5.78M | Buy |
134,292
+3,800
| +3% | +$163K | 3.05% | 18 |
|
|
2021
Q2 | $5.11M | Buy |
130,492
+6,707
| +5% | +$263K | 2.83% | 21 |
|
|
2021
Q1 | $4.49M | Sell |
123,785
-3,185
| -3% | -$115K | 2.75% | 21 |
|
|
2020
Q4 | $4.67M | Buy |
126,970
+2,878
| +2% | +$106K | 2.94% | 19 |
|
|
2020
Q3 | $4.55M | Buy |
124,092
+1,942
| +2% | +$71.3K | 3.19% | 17 |
|
|
2020
Q2 | $3.99M | Buy |
122,150
+4,166
| +4% | +$136K | 3.14% | 19 |
|
|
2020
Q1 | $3.85M | Buy |
117,984
+1,572
| +1% | +$51.3K | 3.7% | 16 |
|
|
2019
Q4 | $4.56M | Buy |
116,412
+4,959
| +4% | +$194K | 3.63% | 16 |
|
|
2019
Q3 | $4.01M | Buy |
111,453
+7,176
| +7% | +$258K | 3.36% | 16 |
|
|
2019
Q2 | $4.52M | Buy |
104,277
+1,591
| +2% | +$68.9K | 4.14% | 10 |
|
|
2019
Q1 | $4.36M | Buy |
102,686
+404
| +0.4% | +$17.2K | 4.27% | 9 |
|
|
2018
Q4 | $4.47M | Buy |
+102,282
| New | +$4.47M | 5% | 2 |
|